| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/08/2013 | EP2588498A1 Llt-1 antibodies with new functional properties |
| 05/08/2013 | EP2588490A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 05/08/2013 | EP2588479A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 05/08/2013 | EP2588478A1 Azaindole derivative |
| 05/08/2013 | EP2588473A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588469A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588458A1 Novel tetrahydroquinoline derivatives |
| 05/08/2013 | EP2588457A1 Pyrazolo-quinolines |
| 05/08/2013 | EP2588453A1 Compositions and methods for modulating the wnt signaling pathway |
| 05/08/2013 | EP2588124A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 05/08/2013 | EP2588110A1 Methods of targeting pten mutant diseases and compositions therefor |
| 05/08/2013 | EP2588107A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| 05/08/2013 | EP2588105A1 Triazolopyridines as tyk2 inhibitors |
| 05/08/2013 | EP2340851A9 Diagnosis method and therapeutic method for cancer |
| 05/08/2013 | CN103097535A Method for producing novel hipsc by means of sirna introduction |
| 05/08/2013 | CN103097413A Lipid-conjugated antibodies |
| 05/08/2013 | CN103097397A Mitochondrial penetrating peptides as carriers for anticancer compounds |
| 05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 05/08/2013 | CN103097390A Application of beta-functionalized dihydroxy-chlorins for PDT |
| 05/08/2013 | CN103097388A New aminopyrazoloquinazolines |
| 05/08/2013 | CN103097386A Lipidated immune response modifier compound compositions, formulations, and methods |
| 05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
| 05/08/2013 | CN103097380A Inhibitor of casein kinase 1[delta] and casein kinase 1[epsilon] |
| 05/08/2013 | CN103097374A Metalloenzyme inhibitor compounds |
| 05/08/2013 | CN103097368A Tricyclic lactones for treatment of cancer |
| 05/08/2013 | CN103097361A 1-(aryl methyl)-quinazoline-2,4-dione as parp inhibitor and its application |
| 05/08/2013 | CN103097353A Novel immunomodulator and anti inflammatory compounds |
| 05/08/2013 | CN103096933A Multifunctional antibody conjugates |
| 05/08/2013 | CN103096914A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| 05/08/2013 | CN103096913A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
| 05/08/2013 | CN103096912A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| 05/08/2013 | CN103096911A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| 05/08/2013 | CN103096910A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
| 05/08/2013 | CN103096899A Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 05/08/2013 | CN103096884A Cancer heat therapy-enhancing agent |
| 05/08/2013 | CN103088083A Method for preparing anti-inflammation and anti-tumor activity sesquiterpene lactone compounds |
| 05/08/2013 | CN103088064A Liver cancer tissue specific RNA (Ribose Nucleic Acid) interference system, as well as construction method and application method thereof |
| 05/08/2013 | CN103088061A Application of RNA and carrier in preparation of product for preventing and/or treating liver cancer |
| 05/08/2013 | CN103088049A DNA (Deoxyribose Nucleic Acid)-based infectious clone of a Japanese encephalitis virus SA14-14-2 strain, as well as construction method and application thereof |
| 05/08/2013 | CN103088029A Double-enhancer alpha fetoprotein (AFP) recombination promoter and application thereof |
| 05/08/2013 | CN103088028A shRNA (short hairpin ribonucleic acid) of silent human breast cancer specific gene |
| 05/08/2013 | CN103087325A Ferrocenyl-containing tricyclohexyltin coordination polymer, and preparation method and application thereof |
| 05/08/2013 | CN103087215A Method for extracting and purifying antitumor polysaccharide components in sargassum muticum |
| 05/08/2013 | CN103087200A Pig IFN (interferon) gamma-Fc fusion protein as well as coding gene and expression method of pig IFN (interferon) gamma-Fc fusion protein |
| 05/08/2013 | CN103087199A Gastric cancer targeted recombinant toxin and preparation method thereof |
| 05/08/2013 | CN103087196A Preparation method of muramyl dipeptide-anti-CD20 immune conjugate and application thereof |
| 05/08/2013 | CN103087192A Anti-KDR antibodies and methods of use |
| 05/08/2013 | CN103087172A Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
| 05/08/2013 | CN103087141A Anti-tumor angiogenesis usage of tripterygium glycosides extractive wilforol B as KDR inhibitor |
| 05/08/2013 | CN103087122A Preparation method and applications of glucoside compounds |
| 05/08/2013 | CN103087119A Flax cerebroside compound and extraction and separation method thereof |
| 05/08/2013 | CN103087115A Ferrocenyl-containing tributyltin benzoate coordination polymer, and preparation method and application thereof |
| 05/08/2013 | CN103087110A Saw horse carbonyl ruthenium compound and preparation method thereof |
| 05/08/2013 | CN103087107A Single catechol molybdenum complex, preparation method thereof and application thereof |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087077A Thienopyrimidine and furopyrimidine derivative, its preparation method and application in medicines |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087054A 4-pyridyl phenyl ether compounds, and preparation method and application thereof |
| 05/08/2013 | CN103087050A Aryl kinase inhibitor |
| 05/08/2013 | CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof |
| 05/08/2013 | CN103087031A Application of bistetrahydrobenzopyrone dimer compounds in anti-cancer drugs |
| 05/08/2013 | CN103087030A Preparation method, biological activity and application of novel exo-methylene lactone tetracyclic diterpenoid compounds |
| 05/08/2013 | CN103087021A Sesquiterpenes ester compound, as well as preparation method and use thereof |
| 05/08/2013 | CN103086995A 2-[4-(benzoxazole-2-oxygroup) phenoxy] alkylamide and application thereof |
| 05/08/2013 | CN103086994A Salts of isoxazole derivatives |
| 05/08/2013 | CN103086985A 2-[4-(quinoxaline-2-oxygroup) phenoxy] alkylamide and application thereof |
| 05/08/2013 | CN103086984A 4-phenylamino quinazoline derivative, preparation method and application thereof |
| 05/08/2013 | CN103086982A Pyrimidine derivative salts |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof |
| 05/08/2013 | CN103086975A 9-hydroxymethyl-10-imidazolanthracenehydrazone, and synthetic method and application thereof |
| 05/08/2013 | CN103086972A Preparation of pyrazole-acylhydrazone compounds and application of pyrazole-acylhydrazone compounds in anticancer treatment |
| 05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
| 05/08/2013 | CN103086970A Synthesis and preparation method and antimicrobial and anticancer functions of 3,5-diphenyl-2H-pyrazole derivatives with trifluorotolyl group |
| 05/08/2013 | CN103086958A NF[kappa]B pathway activation inhibitor, preparation method thereof, pharmaceutical composition and purpose |
| 05/08/2013 | CN103086947A Phthalimide compounds with antiangiogenic activity and purpose thereof |
| 05/08/2013 | CN103086943A Indoles derivative functioning as CRTH2 receptor antagonist |
| 05/08/2013 | CN103086935A Diphenyl selenide, diphenyl selenoxide, diphenyl selenone compounds and uses thereof |
| 05/08/2013 | CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use |
| 05/08/2013 | CN103086921A 2-(4-aryloxyphenoxy)alkylamide and application thereof |
| 05/08/2013 | CN103086864A Shikonin tetramer compound and purpose thereof in pharmacy |
| 05/08/2013 | CN103086863A Alkannin dimer compounds and uses of the same in drug preparation |
| 05/08/2013 | CN103083686A Application of DKK4 gene and coding protein thereof in preparation of medicament |
| 05/08/2013 | CN103083685A Method for reversing drug resistance of breast cancer by using miR-181a |
| 05/08/2013 | CN103083682A Folic acid modified chitosan quaternary ammonium salt-taxol polymer medicine, as well as preparation method and application thereof |
| 05/08/2013 | CN103083681A Drug for treating tumors and application thereof |
| 05/08/2013 | CN103083680A Polyethylene glycol (PEG)-amino acid oligopeptide-irinotecan combo and its medicinal composition |
| 05/08/2013 | CN103083678A Method for modifying uricase by active polyethylene glycol (PEG) against amino group under protection of competitive inhibitor |
| 05/08/2013 | CN103083673A Novel anti-tumor nano-drug carrier and preparation method and application thereof |
| 05/08/2013 | CN103083671A Medicine composition of tyrosine kinase inhibitor and histone deacetylase inhibitor |
| 05/08/2013 | CN103083666A Drug composition, drug composition preparation and drug composition uses |
| 05/08/2013 | CN103083665A Destruction of tumor cells by trifunctional bispecific antibodies with low to medium expression levels of tumor-associated target antigens |
| 05/08/2013 | CN103083661A Application of carbon nanotube in preparation of immunostimulant of anti-tumor immunotherapy medicine |
| 05/08/2013 | CN103083644A Dimeric iap inhibitors |
| 05/08/2013 | CN103083642A Aloe preparation for skin enhancement |
| 05/08/2013 | CN103083620A Traditional Chinese medicine composition for preventing and treating postoperative recurrence of cancer |